Construction of a novel ceRNA network and identification of lncRNA ADAMTS9-AS2 and PVT1 as hub regulators of miRNA and coding gene expression in gastric cancer
Authors:
Open Access
- 1 February 2021
- journal article
- research article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 10 (2) , 938-952
Abstract
Background: Studies on the interactions of single long non-coding RNA, microRNA, and mRNA have many limitations; therefore, it is necessary to study the complex regulatory network of gastric cancer (GC) pathogenesis systematically. Methods: In this study, gene and miRNA expression data for GC were downloaded from The Cancer Genome Atlas and used for transcriptome profiling, differential gene analysis, and construction of an lncRNA-miRNA-mRNA regulatory network in conjunction with an online database to identify the key genes and subnetworks in GC pathogenesis. Real-time quantitative polymerase chain reaction was used to detect the expression of hub lncRNAs in 54 paired GC and matched normal mucosal tissues. Results: We constructed an lncRNA-miRNA-mRNA competitive endogenous RNA regulatory network containing 1,626 network nodes and 2,704 interactions. LncRNA ADAMTS9-AS2 and PVT1 were identified as key node genes in this competitive endogenous RNA network. Quantitative reverse transcription-polymerase chain reaction revealed ADAMTS9-AS2 downregulation and PVT1 upregulation in 54 pairs of GC and normal tissues adjacent to the cancer tissues. Conclusions: This study systematically analysed the lncRNA-miRNA-mRNA regulatory network in GC and identified ADAMTS9-AS2 and PVT1 as key regulatory genes in this network, providing new understanding of GC pathogenesis and insights for its early diagnosis and treatment.Keywords
This publication has 31 references indexed in Scilit:
- The Interaction Between MiR-141 and lncRNA-H19 in Regulating Cell Proliferation and Migration in Gastric CancerCellular Physiology and Biochemistry, 2015
- Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancerBritish Journal of Cancer, 2015
- MicroRNA biogenesis pathways in cancerNature Reviews Cancer, 2015
- Microarray analysis of the aberrant microRNA expression pattern in gliomas of different gradesOncology Reports, 2015
- Serum miR-200c Is a Novel Prognostic and Metastasis-Predictive Biomarker in Patients With Colorectal CancerAnnals of Surgery, 2014
- Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first‐line oxaliplatin‐based treatmentMolecular Oncology, 2013
- Serum MicroRNA-155 as a Potential Biomarker to Track Disease in Breast CancerPLOS ONE, 2012
- Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast CancerPLOS ONE, 2012
- Non-coding RNAs in human diseaseNature Reviews Genetics, 2011
- A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2005